Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment-Reference-Cited by-同舟云学术

Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment

Published:2023-10 Issue: Volume:362 Page:524-535
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Huang Shigao,Xing Fuqiang,Dai Yeneng,Zhang Zhiming,Zhou Guangyu,Yang Shuo,Liu Yu-Cheng,Yuan Zhen,Luo Kathy Qian,Ying Tianlei,Chu Dafeng,Liu Tzu-Ming,Deng Chu-Xia,Zhao Qi

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. 2022 update on the scientific premise and clinical trials for IL-15 agonists as cancer immunotherapy;Peng;J. Leukoc. Biol.,2022

2. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N. Engl. J. Med.,2013

3. Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential;Zhao;Leukemia,2015

4. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes;Liu;J. Hematol. Oncol.,2021

5. Remodeling of tumor microenvironment by tumor-targeting Nanozymes enhances immune activation of CAR T cells for combination therapy;Zhu;Small,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering cells or cellular outer membranes as multifaceted vehicles for reinforcing nanomedicine-based pulmonary disease treatment;Nano Today;2024-10

2. The Evolution of Microfluidic‐Based Drug‐Loading Techniques for Cells and Their Derivatives;Small;2024-08-17